The closing price of Pacific Biosciences of California Inc (NASDAQ: PACB) was $3.79 for the day, down -3.07% from the previous closing price of $3.91. In other words, the price has decreased by -$0.1200 from its previous closing price. On the day, 6645329 shares were traded. PACB stock price reached its highest trading level at $3.9800 during the session, while it also had its lowest trading level at $3.7300.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our analysis of PACB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.21 and its Current Ratio is at 7.81. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on December 14, 2023, initiated with a Overweight rating and assigned the stock a target price of $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 06 ’24 when Meline David W bought 40,000 shares for $4.40 per share. The transaction valued at 176,160 led to the insider holds 40,000 shares of the business.
HENRY CHRISTIAN O sold 14,177 shares of PACB for $69,056 on Mar 04 ’24. The insider now owns 2,596,670 shares after completing the transaction at $4.87 per share. On Mar 04 ’24, another insider, Van Oene Mark, who serves as the insider of the company, sold 9,186 shares for $4.87 each. As a result, the insider received 44,745 and left with 1,668,826 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 1.02B and an Enterprise Value of 1.32B. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.06 while its Price-to-Book (P/B) ratio in mrq is 1.45. Its current Enterprise Value per Revenue stands at 6.57 whereas that against EBITDA is -4.75.
Stock Price History:
Over the past 52 weeks, PACB has reached a high of $14.55, while it has fallen to a 52-week low of $3.86. The 50-Day Moving Average of the stock is 6.1024, while the 200-Day Moving Average is calculated to be 9.2472.
Shares Statistics:
PACB traded an average of 8.70M shares per day over the past three months and 10.59M shares per day over the past ten days. A total of 267.74M shares are outstanding, with a floating share count of 252.00M. Insiders hold about 5.95% of the company’s shares, while institutions hold 98.51% stake in the company. Shares short for PACB as of Feb 29, 2024 were 43.54M with a Short Ratio of 5.00, compared to 34.19M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 16.25% and a Short% of Float of 18.01%.
